Astrelis
Dialysis facility · PR

DIALYSIS 402548

CCN 402548Latest FY 2023
Cost-report basis
HCRIS · as filed
Not audited by Astrelis
The read

A dialysis facility in PR. It ran an operating loss of 0.8% in FY22 on $4.3M of operating revenue. It held 19 days of cash on hand (33rd percentile among dialysis facilities on liquidity). Operating margin declined from 4.0% in FY20 to -0.8% in FY22.

Operating margin · FY22
-0.8%
8.0 pts vs FY21
vs dialysis facilities26th pctl of 7,741
Days cash on hand · FY22
19d
all sources
16.8 days vs FY21
vs dialysis facilities33rd pctl
Total operating revenue · FY22
$4.3M
0.4 $M vs FY21
vs dialysis facilities69th pctl
Total margin · incl. nonoperating · FY22
-0.8%
8.0 pts vs FY21
vs dialysis facilities26th pctl

Where DIALYSIS 402548 sits among dialysis facilities

Operating margin · FY23 pool · n = 7,741 of 7,741 filed

Each point is one dialysis facility in the national distribution for this provider type, placed by operating margin. Facilities are not matched on size, case mix, or market — that is the matched-peer comparison in the paid benchmark. The dialysis facility median is +11.9%. Descriptive context only, not a ranking.

-20%-10%0%+10%+20%dialysis facility median +11.9%DIALYSIS 402548 -0.77%-20%0%+20%dialysis facility median +11.9%DIALYSIS 402548 -0.77%
One dialysis facilityDIALYSIS 402548dialysis facility median

The money

$ thousands · HCRIS cost-report basis · as filed, QA-gated

Ratios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio renders only when every input is reported in the filing; a year missing its core lines is not shown; a year whose balance sheet does not reconcile is labeled. Not audited by Astrelis.

Operating margin
-0.8% (FY22)
Operating income ÷ total operating revenue
HCRIS WS G-3
Total margin
-0.8% (FY22)
Net income ÷ total revenue incl. nonoperating
HCRIS WS G-3
Days cash on hand
19d (FY22)
Cash & investments ÷ daily operating expense
HCRIS WS G / G-3
Current ratio
1.80× (FY22)
Total current assets ÷ current liabilities
HCRIS WS G
Equity financing ratio
-65% (FY22)
Total net assets ÷ total assets
HCRIS WS G
Days in net patient A/R
43d (FY22)
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
HCRIS WS G / G-3
$ in thousands
Line itemFY20FY21FY22
Patient revenue4,0834,6794,264
Total operating revenue4,0834,6794,264
Total operating expenses3,9184,3404,297
Operating income166338(33)
Operating margin %+4.1%+7.2%-0.8%
Net income166338(33)
Net income %+4.1%+7.2%-0.8%
HCRIS CMS-265 cost report · $ thousands · FY20–FY23 · operating revenue reflects net patient service revenue · FY20–21 may include COVID-era relief funding

Trajectory

Cost-report basis · 4 reporting years
Operating margin
+4.0%+7.2%-0.8%FY20FY21FY22FY23
Days cash on hand
33 days35 days19 daysFY20FY21FY22FY23

The county this dialysis facility serves

Location, PR
County demographic and economic context (Census, CDC, HRSA sources) extends to this dialysis facility cohort in an upcoming release.
build aa21187 · 2026-07-28